USP in the News

professional examining prescription bottle
Center for Biosimilars
Little-Known Provision of Senate Healthcare Bill Has Some Biosimilar Stakeholders Worried

One provision of the Lower Health Care Costs Act that has garnered significantly less attention from the broader healthcare community has raised concerns among many biologics stakeholders.

pharmacist and customer reviewing prescription
Commentary on the Benefits of US Pharmacopeial Standards: A Generic Pharmaceutical Industry Survey

Unpublished data suggest that pharmacopeial quality standards, while not associated with increasing the likelihood of a first generic entrant in the market, are associated with increasing the overall number of generic entrants.

Stay Connected
Stay Connected…

Sign up for the latest USP News Releases!